Abstract
PD-L1 (CD274) amplification occurs in a small subset of malignancies and may predict anti-PD-1/PD-L1 immunotherapy responsiveness. We hypothesized that both copy number (CN) and focality of cancer-related PD-L1 amplifications impact...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have